AML with BCR-ABL1 Fusion treated with Imatinib, a Hypomethylating Agent and Venetoclax

A patient with history of myelodysplastic syndrome (MDS) presented with multifocal pneumonia and was found to have Philadelphia chromosomepositive (Ph+) acute myeloid leukemia (AML). A tyrosine kinase inhibitor (TKI) was added to decitabine and venetoclax combination, providing a molecular and cytog...

Descripción completa

Detalles Bibliográficos
Autores principales: Low, Soon Khai, Nanua, Suparna, Patel, Mehul, Renteria, Anne S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240361/
https://www.ncbi.nlm.nih.gov/pubmed/35782581
http://dx.doi.org/10.1016/j.lrr.2022.100333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240361/
https://www.ncbi.nlm.nih.gov/pubmed/35782581
http://dx.doi.org/10.1016/j.lrr.2022.100333

Ejemplares similares